These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12233903)

  • 21. [Treatment of rheumatoid arthritis].
    Babić-Naglić D
    Reumatizam; 2003; 50(2):22-7. PubMed ID: 15098369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P; Levine M; Gaebel K; Thabane L
    Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritis.
    Smolen JS; Aletaha D
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):296-7. PubMed ID: 18461061
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
    Cohen SB
    Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?
    Boers M
    Arthritis Rheum; 2003 Jun; 48(6):1481-3. PubMed ID: 12794813
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of the American College of Rheumatology N (ACR-N) index of improvement in rheumatoid arthritis: argument in favor.
    Siegel JN; Zhen BG
    Arthritis Rheum; 2005 Jun; 52(6):1637-41. PubMed ID: 15934067
    [No Abstract]   [Full Text] [Related]  

  • 27. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study.
    Anderson JJ; Bolognese JA; Felson DT
    Arthritis Rheum; 2003 Nov; 48(11):3031-8. PubMed ID: 14613263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Better observational studies make better economic evaluations.
    Roger L
    J Rheumatol; 2000 Aug; 27(8):2052-3. PubMed ID: 10955358
    [No Abstract]   [Full Text] [Related]  

  • 31. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy.
    Alarcón GS
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):296-7. PubMed ID: 16932705
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes?
    Dougados M; Smolen JS
    J Rheumatol Suppl; 2002 Nov; 66():20-6. PubMed ID: 12435165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study.
    Brulhart L; Ciurea A; Finckh A; Notter A; Waldburger JM; Kyburz D; Gabay C
    Ann Rheum Dis; 2006 Sep; 65(9):1255-7. PubMed ID: 16540545
    [No Abstract]   [Full Text] [Related]  

  • 34. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience.
    Kaarela K; Hakala M; Hannonen P; Kautiainen H; Korpela M; Leirisalo-Repo M; Luosujärvi R; Luukkainen R; Möttönen T; Puolakka K
    Rheumatology (Oxford); 2005 Jan; 44(1):134-5; author reply 135-6. PubMed ID: 15611310
    [No Abstract]   [Full Text] [Related]  

  • 36. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
    Yazici Y; Abramson SB
    Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in drug therapy for rheumatoid arthritis.
    Malaviya AN; Kaushik P
    J Assoc Physicians India; 1999 Sep; 47(9):912-7. PubMed ID: 10778664
    [No Abstract]   [Full Text] [Related]  

  • 38. [Early therapy -- later retirement].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):6, 8. PubMed ID: 15887692
    [No Abstract]   [Full Text] [Related]  

  • 39. Two is better than one? Combination therapy in rheumatoid arthritis.
    Choy EH
    Rheumatology (Oxford); 2004 Oct; 43(10):1205-7. PubMed ID: 15226519
    [No Abstract]   [Full Text] [Related]  

  • 40. Are biologics more effective than classical disease-modifying antirheumatic drugs?
    Nurmohamed MT; Dijkmans BA
    Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.